Figshare最新文献

筛选
英文 中文
Mitochondria-TargetednMultifunctional Nanoprodrugsnby Inhibiting Metabolic Reprogramming for Combating Cisplatin-ResistantnLung Cancer 线粒体靶向多功能纳米药物抑制代谢重编程治疗顺铂耐药肺癌
Figshare Pub Date : 2024-08-01 DOI: 10.1021/acsnano.4c04024.s001
Haibin Lu (3153807), Weifang Tong (2070619), Meixu Jiang (12870765), Huimin Liu (284624), Chen Meng (411751), Kai Wang (21246), Xupeng Mu (5811020)
{"title":"Mitochondria-TargetednMultifunctional Nanoprodrugsnby Inhibiting Metabolic Reprogramming for Combating Cisplatin-ResistantnLung Cancer","authors":"Haibin Lu (3153807), Weifang Tong (2070619), Meixu Jiang (12870765), Huimin Liu (284624), Chen Meng (411751), Kai Wang (21246), Xupeng Mu (5811020)","doi":"10.1021/acsnano.4c04024.s001","DOIUrl":"https://doi.org/10.1021/acsnano.4c04024.s001","url":null,"abstract":"How to address the resistance ofncisplatin (CDDP) has always beenna clinical challenge. The resistance mechanism of platinum-based drugsnis very complex, including nuclear DNA damage repair, apoptosis escape,nand tumor metabolism reprogramming. Tumor cells can switch betweennmitochondrial oxidative phosphorylation (OXPHOS) and glycolysis andndevelop resistance to chemotherapy drugs through metabolic variability.nIn addition, due to the lack of histone protection and a relativelynweak damage repair ability, mitochondrial DNA (mtDNA) is more susceptiblento damage, which in turn affects mitochondrial OXPHOS and can becomena potential target for platinum-based drugs. Therefore, mitochondria,nas targets of anticancer drugs, have become a hot topic in tumor resistancenresearch. This study constructed a self-assembled nanotargeted drugndelivery system LND-SS-Pt-TPP/HA-CD. β-Cyclodextrin-graftednhydronic acid (HA-CD)-encapsulated prodrug nanoparticles can targetnCD44 on the tumor surface and further deliver the prodrug to intracellularnmitochondria through a triphenylphosphine group (TPP<sup>+</sup>).nDisulfide bonds can be selectively degraded by glutathione (GSH) innmitochondria, releasing lonidamine (LND) and the cisplatin prodrugn(Pt(IV)). Under the action of GSH and ascorbic acid, Pt(IV) is furthernreduced to cisplatin (Pt(II)). Cisplatin can cause mtDNA damage, inducenmitochondrial dysfunction and mitophagy, and then affect mitochondrialnOXPHOS. Meanwhile, LND can reduce the hexokinase II (HK II) level,ninduce destruction of mitochondria, and block energy supply by glycolysisninhibition. Ultimately, this self-assembled nano targeted deliverynsystem can synergistically kill cisplatin-resistant lung cancer cells,nwhich supplies an overcome cisplatin resistance choice via the disruptnmitochondria therapy.","PeriodicalId":521671,"journal":{"name":"Figshare","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147883616","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书